GlassScriptPhysician profile
Russell Van Husen
NPI 1912101361
$10,862.42
in general payments reported to CMS, 2019-2025
38 companies · $3,480 in 2025
The $3,480 reported for 2025 was more than what 80% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,581 · 2020: $249 · 2021: $1,381 · 2022: $566 · 2023: $817 · 2024: $2,787 · 2025: $3,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $3,654 · Food and Beverage: $2,674 · Travel and Lodging: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $3,654.22 |
| Food and Beverage | $2,673.69 |
| Travel and Lodging | $757.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $3,038.91 | 2021-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Silk Road Medical, INC. | $1,109.02 | 2019-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Integra Lifesciences Corporation | $883.46 | 2020-2025 | Micromatrix, Integra, Primatrix |
| Intuitive Surgical, INC. | $856.86 | 2021-2024 | |
| W. L. Gore & Associates, INC. | $846.64 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Ethicon US, LLC | $835.07 | 2019-2024 | Linx Reflux Management System, Stratafix |
| Medtronic, INC. | $727.14 | 2021-2025 | Abre, Ellipsys Vascular Access System, Nanocross Elite |
| Medical Device Business Services, INC. | $479.53 | 2024 | Linx Reflux Management System |
| Davol INC. | $422.99 | 2024-2025 | Phasix Mesh |
| Tactile Systems Technology INC | $318.31 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Endologix LLC | $261.92 | 2023 | Alto Abdominal Stent Graft System |
| Inari Medical, INC. | $157.69 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $110.13 | 2019-2020 | |
| Boston Scientific Corporation | $86.28 | 2024-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Bolton Medical INC | $66.14 | 2020-2023 | Treo Abdominal Stent-Graft System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $61.33 | 2019-2025 | Pico 7, Pico |
| Stryker Corporation | $60.88 | 2025 | Artix Mt |
| Cook Medical LLC | $45.30 | 2025 | Zenith Alpha, Rosen |
| Lemaitre Vascular, INC. | $44.79 | 2023 | Anastoclip Gc 8cm (Medium), Artegraft Vascular Graft |
| Vertex Pharmaceuticals Incorporated | $44.78 | 2025 | |
| Reflow Medical INC | $44.24 | 2025 | |
| Innovation Technologies INC | $40.68 | 2022 | |
| Tela Bio, INC. | $36.35 | 2020-2021 | |
| Bioventus LLC | $32.41 | 2023 | |
| Portola Pharmaceuticals, LLC | $26.62 | 2019 | |
| Potrero Medical, INC. | $25.69 | 2021 | |
| Kerecis Limited | $19.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Teleflex LLC | $19.37 | 2022 | |
| Conmed Corporation | $18.74 | 2023 | Airseal |
| Solventum Corporation | $18.24 | 2024 | Activ.A.C. |
| Abiomed | $17.40 | 2024 | Impella |
| Penumbra, INC. | $17.14 | 2020 | |
| Avinger INC. | $17.09 | 2022 | |
| Lifenet Health | $16.22 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $16.04 | 2019 | |
| Baxter Healthcare | $15.04 | 2023 | Peri-Strips Dry |
| Allergan, INC. | $13.05 | 2019 | |
| Elucent Medical | $11.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Van Husen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.